PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury

28Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Phenylacetylglutamine (PAGln), a gut microbiota (GM)-derived metabolite, is associated with cardiovascular disease. Studies have shown that disordered GM participated in the progression of atrial fibrillation (AF), but the relationship between PAGln and AF is unclear. This study investigated the characteristics of PAGln in AF patients and its impact on atrial myocytes. Based on our previous metagenomic data, the relative abundance of porA, a critical bacterial enzyme for PAGln synthesis, exhibited an increased tendency in AF. In an independent cohort consisting of 42 controls without AF and 92 AF patients, plasma PAGln levels were higher in AF patients than in controls (p < 0.001) by immunoassay. Notably, PAGln exerted a predictive potential of AF with an AUC of 0.774 (p < 0.001), and a predictive model constructed based on the PAGln and Taiwan AF score further improved the predictive potential. Furthermore, a positive correlation was determined between PAGln and LA diameter. Subsequently, the effect of PAGln intervention was examined on HL-1 cells in vitro, revealing that PAGln increased apoptosis, reactive oxygen species (ROS) production, CaMKII and RyR2 activation and decreased cell viability. In conclusion, increased PAGln was associated with AF, and PAGln might contribute to the AF pathogenesis by promoting oxidative stress and apoptosis in atrial myocytes.

References Powered by Scopus

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

7554Citations
N/AReaders
Get full text

Gut microbiota in cardiovascular health and disease

1182Citations
N/AReaders
Get full text

Atrial remodeling and atrial fibrillation: mechanisms and implications.

912Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy

96Citations
N/AReaders
Get full text

Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?

29Citations
N/AReaders
Get full text

Gut Microbiome-Based Management of Patients With Heart Failure: JACC Review Topic of the Week

17Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fang, C., Zuo, K., Jiao, K., Zhu, X., Fu, Y., Zhong, J., … Yang, X. (2022). PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury. Biomolecules, 12(8). https://doi.org/10.3390/biom12081120

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

75%

Researcher 1

25%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 3

75%

Medicine and Dentistry 1

25%

Save time finding and organizing research with Mendeley

Sign up for free